Comparative Efficacy and Tolerability of Neoadjuvant Immunotherapy Regimens for Patients with HER2-Positive Breast Cancer: A Network Meta-Analysis

Figure 1

Summary of trial selection for network meta-analysis. HER2 indicates human epidermal growth factor receptor 2.